X0407 4/A 2022-02-04 2022-02-08 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001855980 Secora Michael C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 0 1 0 0 Chief Financial Officer 0 Class A Common Stock 2022-02-04 4 A 0 58342 0.00 A 589101 D Class A Common Stock 2022-02-04 4 A 0 1957 0.00 A 591058 D Class A Common Stock 2022-02-04 4 F 0 678 11.40 D 590380 D This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter. Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021 and 609 shares received pursuant to a pro rata distribution from Catalio Nexus Fund II, LP, of which the Reporting Person was a limited partner (the acquisition of such shares from Catalio was inadvertently excluded from the total shares held in the original Form 4 filing and is exempt pursuant to Rule 16a-9). This RSU vested immediately upon the grant date. /s/ Jonathan Golightly, attorney-in-fact 2023-04-28